Inventor
TANGY FREDERIC
FR23 patents
⚠️ This page may combine multiple inventors who share the name “TANGY FREDERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PASTEUR INSTITUT
15 patentsUS7556812B2Jul 7, 2009
Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
PASTEUR INSTITUT14 citations92
US8343718B2Jan 1, 2013
Strain of SARS-associated coronavirus and applications thereof
PASTEUR INSTITUT22 citations87
US7736850B2Jun 15, 2010
Strain of SARS-associated coronavirus and applications thereof
PASTEUR INSTITUT18 citations87
US9889193B2Feb 13, 2018
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
PASTEUR INSTITUT2 citations68
US9655961B2May 23, 2017
Recombinant measles virus expressing chikungunya virus polypeptides and their applications
PASTEUR INSTITUT3 citations68
US11020473B2Jun 1, 2021
Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
PASTEUR INSTITUT2 citations66
US12533404B2Jan 27, 2026
Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
PASTEUR INSTITUT0 citations56
US11034730B2Jun 15, 2021
Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
PASTEUR INSTITUT1 citations56
US10316066B2Jun 11, 2019
Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
PASTEUR INSTITUT1 citations55
US9499799B2Nov 22, 2016
Cells and methodology to generate non-segmented negative-strand RNA viruses
PASTEUR INSTITUT0 citations51
US11857616B2Jan 2, 2024
Recombinant measles virus expressing zika virus prM and E proteins
PASTEUR INSTITUT0 citations50
US10227385B2Mar 12, 2019
Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
PASTEUR INSTITUT0 citations50
US9579375B2Feb 28, 2017
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
PASTEUR INSTITUT0 citations50
US11160858B2Nov 2, 2021
Live recombinant measles-M2 virus—its use in eliciting immunity against influenza viruses
PASTEUR INSTITUT0 citations41
US10300128B2May 28, 2019
Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides
PASTEUR INSTITUT0 citations39
TANGY FREDERIC
8 patentsUS8586364B2Nov 19, 2013
Cells and methodology to generate non-segmented negative-strand RNA viruses
TANGY FREDERIC12 citations83
US8853379B2Oct 7, 2014
Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
TANGY FREDERIC9 citations81
US8337857B2Dec 25, 2012
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
TANGY FREDERIC11 citations81
US10793877B2Oct 6, 2020
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
TANGY FREDERIC5 citations80
US10519466B2Dec 31, 2019
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
TANGY FREDERIC5 citations80
US9701944B2Jul 11, 2017
Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
TANGY FREDERIC5 citations78
US9914937B2Mar 13, 2018
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
TANGY FREDERIC3 citations69
US12163150B2Dec 10, 2024
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
TANGY FREDERIC0 citations59